Pelayo-Terán José María, Gajardo Galán Virginia Gajardo, de la Ortiz-García de la Foz Víctor, Martínez-García Obdulia, Tabarés-Seisdedos Rafael, Crespo-Facorro Benedicto, Ayesa-Arriola Rosa
Department of Medicine and Psychiatry, University Hospital Marques de Valdecilla, School of Medicine, University of Cantabria-IDIVAL, Santander, Spain.
Centro Investigación Biomédica en Red Salud Mental (CIBERSAM), Santander, Spain.
Eur Arch Psychiatry Clin Neurosci. 2017 Jun;267(4):315-323. doi: 10.1007/s00406-016-0740-3. Epub 2016 Oct 28.
Relapses may represent a critical hazard in schizophrenia spectrum disorders as they are associated with an increased risk of a clinical and functional deterioration. Preventing relapse after recovering from a first psychotic episode has become a major challenge due to its critical impact on lifelong functionality. This study explored the rate of first and second relapses and the predictors associated with these relapses in a large cohort of non-affective psychosis patients during a period of 3 years after the first break of the illness. From February 2001 to May 2014, sociodemographic and clinical data from an epidemiological cohort of 341 non-affective first-episode psychosis patients at risk of relapse were analysed at a specialized early intervention service. Logistic regression, Cox regression, and Kaplan-Meier survival analyses were performed to compare non-relapsed and relapsed patients. One hundred and sixty-six (48.7%) individuals relapsed at least once. Median time to relapse was 17.0 months in non-adherent patients and 40.0 months in adherent patients (log-rankχ : 51.36; p < 0.001). Non-adherence to medication (odds ratio-OR 2.979; p < 0.001), schizophrenia diagnosis (OR 2.173; p = 0.002), and age of onset (OR 1.020; p = 0.033) were the main predictors of the first relapse. Fifty-six subjects experienced a second relapse (33.73%) predicted by diagnosis (OR 1.975; p = 0.074), age of onset (OR 1.078; p = 0.003), and positive symptoms (OR 0.863; p = 0.03), but not adherence. Non-adherence is the main predictive factor of first relapse after a first episode of psychosis. Second relapses were not often and not related to modifiable factors, suggesting that multiple relapsed patients may comprise a subgroup with a higher biological risk.
复发可能是精神分裂症谱系障碍中的一个关键危险因素,因为它们与临床和功能恶化风险增加相关。由于首次精神病发作康复后预防复发对终身功能有重大影响,这已成为一项重大挑战。本研究探讨了一大群非情感性精神病患者在首次发病后的3年期间首次和第二次复发的发生率以及与这些复发相关的预测因素。从2001年2月到2014年5月,在一家专门的早期干预服务机构分析了341名有复发风险的非情感性首发精神病患者的流行病学队列的社会人口统计学和临床数据。进行了逻辑回归、Cox回归和Kaplan-Meier生存分析,以比较未复发和复发患者。166名(48.7%)个体至少复发过一次。未坚持服药的患者复发的中位时间为17.0个月,坚持服药的患者为40.0个月(对数秩χ:51.36;p<0.001)。未坚持服药(比值比-OR 2.979;p<0.001)、精神分裂症诊断(OR 2.173;p=0.002)和发病年龄(OR 1.020;p=0.033)是首次复发的主要预测因素。56名受试者经历了第二次复发(33.73%),其预测因素为诊断(OR 1.975;p=0.074)、发病年龄(OR 1.078;p=0.003)和阳性症状(OR 0.863;p=0.03),但与是否坚持服药无关。未坚持服药是首次精神病发作后首次复发的主要预测因素。第二次复发并不常见,且与可改变因素无关,这表明多次复发的患者可能构成一个具有较高生物学风险的亚组。